Latest news with #CGSInternationalSecuritiesMalaysiaSdnBhd
New Straits Times
20-05-2025
- Business
- New Straits Times
CGS International backs Johor-Singapore SEZ with investment pledge
KUALA LUMPUR: CGS International Securities Malaysia Sdn Bhd (CGS MY) has strengthened its commitment to regional investment by signing four strategic Letters of Intent (LOIs) aimed at accelerating the development of the Johor-Singapore Special Economic Zone (JS-SEZ). As one of six financial institutions partnering with the Ministry of Economy, the Johor State government, and the Iskandar Region Development Authority, CGS MY is positioned as a key facilitator in driving economic activity within the JS-SEZ. Chief executive officer Azizah Mohd Yatim said CGS MY is actively engaging with companies to unlock opportunities within the zone, leveraging its regulatory transparency, cross-border connectivity, and attractive incentive framework. "As Asia's global investment house, CGS MY supports businesses in exploring capital access on JS-SEZ incentives, market expansion and strategic partnerships," she said. She added that the LOIs mark a vote of confidence in JS-SEZ appeal as a launchpad for innovation and it represents more than just investment interest. The LOIs were announced at the JS-SEZ Partners Dialogue: Advancing Facilitation on Monday. Positioned as a key regional financial player, CGS MY is aiming to facilitate RM3 billion in foreign direct investment (FDI) within the JS-SEZ over the next three years. In addition, the company is targeting another RM3 billion in assets under management through the development of Single Family Office (SFO) ventures.
New Straits Times
12-05-2025
- Business
- New Straits Times
Pentamaster misses expectations, outlook downgraded
KUALA LUMPUR: Pentamaster Corp Bhd's first quarter net profit of RM9.9 million, which dropped 37 per cent due to weaker revenue from the medical segment, has missed expectations. CGS International Securities Malaysia Sdn Bhd said the results made up only 12 per cent of its full-year estimates and 15 per cent of Bloomberg consensus. The firm expects medical segment revenue to decline by 20 per cent in financial year 2025 (FY25) as more US-based MedTech companies may increasingly seek to re-shore their manufacturing operations. "This trend could be particularly pronounced for companies with existing facilities in the US, potentially limiting strong order wins for Pentamaster compared to our earlier expectations," it said in a note. The firm lowered its earnings forecasts for Pentamaster by 14 per cent-17 per cent for FY25-FY27 to reflect more conservative revenue growth assumptions for its equipment segment amid rising uncertainties in the automotive sector. The firm said that these uncertainties, driven by reciprocal US tariffs, could dampen demand for the group's known good die and burn-in testers. However, Pentamaster's diversification into new growth areas, such as renewable energy and high-performance computing, may alleviate the emerging challenges pertaining to the US tariff situation, added CGS International. "We expect these new segments to contribute five per cent of FY25F revenue, driven by the group's ongoing efforts to expand its sales pipeline," it said. The firm downgraded its call for Pentamaster to 'Hold' from 'Add' with a lower target price of RM2.70 following the earnings revision.
